Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical study
2
×
gene editing
genome editing
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
breakup
bridge bio pharma
ceo
clinical hold
combination
commissioner
congress
crispr
crispr-cas9
data
delisting
democrats
departure
detroit blog main
detroit top stories
disease
drug pricing
editas medicine
eli lilly
enzyme
ethics
What
medicine
2
×
benefit
big
bio
bosley's
bosley’s
bridge
bucks
cas
ceo
crime
crispr
departure
editas
editing
exit
gene
going
guiding
humans
isn't
katrine
landmark
little
morning
moves
nasdaq
personnel
phase
reported
reports
results
roundup
sangamo
study
surprising
therapeutics
trial
u.s
week
Language
Current search:
xconomy.com
×
medicine
×
" clinical study "
×
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
